Rosen Law Firm, a global investor rights law firm, announces the filing
of a class action lawsuit on behalf of purchasers of the securities of
Apyx Medical Corporation (NASDAQ: APYX) from August 1, 2018 through
April 1, 2019, inclusive (the “Class Period”). The lawsuit seeks to
recover damages Apyx investors under the federal securities laws.
To join the Apyx class action, go to https://www.rosenlegal.com/cases-register-1560.html
or call Phillip Kim, Esq. or toll-free at 866-767-3653 or email pkim@rosenlegal.com
or cases@rosenlegal.com for
information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS
MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN
ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD
PLAINTIFF.
According to the lawsuit, defendants throughout the Class Period made
false and/or misleading statements and/or failed to disclose that: (1)
the clinical study on the use of J-Plasma, a plasma-based surgical
product for cutting, coagulation, and ablation of soft tissue, for
dermal resurfacing had not met its primary efficacy endpoint; (2) the
clinical study did not support Apyx’s application for regulatory
clearance; (3) Apyx was unlikely to receive regulatory approval of
J-Plasma for dermal resurfacing; and (4) as a result of the foregoing,
Defendants’ positive statements about Apyx’s business, operations, and
prospects were materially false and/or misleading and/or lacked a
reasonable basis. When the true details entered the market, the lawsuit
claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than June 17, 2019. A
lead plaintiff is a representative party acting on behalf of other class
members in directing the litigation. If you wish to join the litigation,
go to https://www.rosenlegal.com/cases-register-1560.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. of Rosen Law Firm toll free at
866-767-3653 or via e-mail at pkim@rosenlegal.com
or cases@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm,
on Twitter: https://twitter.com/rosen_firm
or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since 2013. Rosen
Law Firm has secured hundreds of millions of dollars for investors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190425006049/en/
Copyright Business Wire 2019